Through allocations, Baxter is limiting how much customers can order based on their past purchases, medical necessity and ...

The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.

Treatments for multiple sclerosis have long focused on slowing or stopping the acute disease process, which moves quickly and ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

A decade into reformulating Pfizer’s oral renal cell carcinoma drug Inlyta (axitinib) into a treatment that can be injected ...

A trial of Biogen’s spinal muscular atrophy (SMA) therapy Spinraza (nusinersen) suggests that a higher dose provides benefits ...

After third-party manufacturing issues led to a December rejection of Zealand Pharma’s pediatric congenital hyperinsulinism (CHI) candidate, the Danish pharma’s latest snub seems to come down to ti | ...